BlackRock Institutional Trust’s XBiotech XBIT Stock Holding History

BlackRock Institutional Trust’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.19M	Buy	216,051 +834	+0.4%	+$11.1K	﹤0.01%	3022
2016 Q3	$2.9M	Buy	215,217 +46,524	+28%	+$683K	﹤0.01%	2916
2016 Q2	$3.53M	Buy	168,693 +134,692	+396%	+$1.94M	﹤0.01%	2828
2016 Q1	$321K	Sell	34,001 -399	-1%	-$3.3K	﹤0.01%	3542
2015 Q4	$374K	Buy	34,400 +1,249	+4%	+$15.9K	﹤0.01%	3554
2015 Q3	$495K	Buy	33,151 +8,049	+32%	+$141K	﹤0.01%	3500
2015 Q2	$393K	Buy	+25,102	New	+$521K	﹤0.01%	3544

Other funds holding XBIT

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Institutional Trust's XBIT Position: Q4 2016 in Review

BlackRock Institutional Trust increased its XBiotech (XBIT) stake by 0.39% in Q4 2016, buying an estimated $11.1K and bringing the position to 216,051 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #3022.

BlackRock Institutional Trust first reported a position in XBIT in Q2 2015 and has held it in 7 quarters since. The position peaked at $3.53M in Q2 2016. 49 funds tracked by Wall St. Rank hold XBIT as of Q4 2016.

BlackRock Institutional Trust held 216,051 shares of XBiotech worth $2.19M as of Q4 2016.
BlackRock Institutional Trust bought 834 XBiotech shares in Q4 2016, an estimated $11.1K.
XBiotech made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3022 holding.
BlackRock Institutional Trust first reported a position in XBiotech in Q2 2015 and has held it in 7 quarters since.
BlackRock Institutional Trust's XBiotech position peaked at $3.53M in Q2 2016.
49 funds tracked by Wall St. Rank held XBiotech as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.